已收盘 09-20 16:00:00 美东时间
-0.080
-1.52%
HC Wainwright & Co. analyst Douglas Tsao reiterates scPharmaceuticals (NASDAQ:SCPH) with a Buy and maintains $18 price target.
08-19 18:51
Maxim Group analyst Naz Rahman reiterated a Buy rating on scPharmaceuticals (SC...
08-17 22:05
In a report released today, Stacy Ku from TD Cowen maintained a Buy rating on s...
08-13 19:18
scPharmaceuticals Inc. (NASDAQ:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce
08-12 21:53
scPharmaceuticals (NASDAQ:SCPH) said it has entered into non-dilutive financings totaling up to $125 million with funds managed by Perceptive Advisors. The company said it has entered into a $75 milli...
08-12 19:08
scPharmaceuticals (SCPH) has issued an update. scPharmaceuticals, Inc. secured ...
08-12 18:41
scPharmaceuticals received $75 million through a combination of debt and royalty financings at close, with access to an additional $50 millionThe term loan refinances existing debt principal; lowers coupon, extends
08-12 18:08
Management to host conference call and webcast at 4:30 p.m. ET BURLINGTON, Mass...
08-09 04:05
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts jus...
05-15 18:40
Major earnings expected after the bell on Tuesday include: Oxford Lane Capital Corp. (OXLC) Capital Southwest Corporation (CSWC) Seadrill Limited (SDRL) Nu Holdings Ltd. (NU) Canoo (GOEV) Other earnin...
05-14 05:35